source
- FDA reports rise in unannounced drug inspections in China and India for FY 2026A senior FDA enforcement official said the agency carried out more surprise drug facility inspections in India and China during fiscal year 2026 than it did in the prior year. The unannounced visi…
- Stakeholders submit over 500 comments urging FDA to shape regulation of generative AI medical devicesOver 500 comments have been filed in response to the FDA's discussion paper on generative AI-enabled medical devices. The feedback reflects a wide range of viewpoints. Some participants recommend…